Tradestie Institutional Equity Comparison Engine

CGON vs TLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin while CGON counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CGON trades at N/M Forward P/E with -4293.5% operating margin (-3.7% YoY revenue) versus TLX at N/M Forward P/E and 6.2% operating margin (+22.3% YoY). In options structure, CGON sits in CONSOLIDATION (85th %ile IV; Dealer Gamma Walls on Pro) against TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
CGON N/M vs TLX N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin -4293.5% vs 6.2% ยท YoY -3.7% vs +22.3%
Momentum & Technical Winner CGON
1Y +124.9% vs -5.8% ยท 52W Pos 84% vs 39%
Options & Structure Winner CGON
CONSOLIDATION (85th %ile IV) vs UNCLASSIFIED (N/A IV)
CGON NASDAQ
CG Oncology, Inc. Common stock
Biological Products, (No Disgnostic Substances)
$84.94
+14.16% 1D
Market Cap $6.3B
1M Return +41.91%
1Y Return +124.93%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 15.0 Fund 44.0 Flow 69.0 Mom 60.0
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.96
-2.98% 1D
Market Cap $3.2B
1M Return -16.23%
1Y Return -5.84%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 64.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CGON +124.93% TLX -5.84% Spread: +130.77 pp (CGON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CGON TTM Op. Margin: -4293.5% TLX TTM Op. Margin: 6.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGON vs TLX. Trailing 12-month operating profitability (CGON -4293.5% vs TLX 6.2%) and valuation multiples (CGON N/M vs TLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CGON (2) vs TLX (7)
Institutional Metric CGON TLX Criterion Row Winner
Market Capitalization Scale $6.3B $3.2B Larger Scale CGON
Trailing P/E Ratio Valuation N/M 93.6x Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -3.7% +22.3% Higher Growth TLX
Operating Margin (TTM) Profitability -4293.5% 6.2% Higher Margin TLX
Net Profit Margin Profitability 0.0% 3.8% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency -28.3% 7.4% Higher ROE TLX
52-Week Range Position Momentum 84% ($37โ€“$94) 39% ($6โ€“$13) Stronger Trend CGON
Beta / 30D Volatility Risk Regime 0.77ฮฒ ยท 86% Vol 0.84ฮฒ ยท 62% Vol Lower Realized Risk TLX
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 46.4 / 100 (HOLD) Higher Composite TLX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CGON vs TLX Buy Guide
CGON CONSOLIDATION
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 85th %ile
IV Regime Extreme (>80th %ile)
Live CGON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CGON nor TLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.